Profound Medical Corp. Files 6-K with Press Release
Ticker: PROF · Form: 6-K · Filed: Sep 4, 2024 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 6-K |
| Filed Date | Sep 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, press-release
TL;DR
Profound Medical Corp. dropped a 6-K with a press release on Sept 4. Check it out.
AI Summary
Profound Medical Corp. filed a Form 6-K on September 4, 2024, to report a press release dated the same day. The press release, attached as Exhibit 99.1, is the primary content of this filing. The company is incorporated in A6 and its fiscal year ends on December 31.
Why It Matters
This filing indicates Profound Medical Corp. is disseminating important information to the public via a press release, which could contain updates on business operations, financial performance, or strategic developments.
Risk Assessment
Risk Level: low — This filing is a routine submission of a press release and does not inherently indicate significant new risks.
Key Players & Entities
- Profound Medical Corp. (company) — Registrant
- September 4, 2024 (date) — Filing and Press Release Date
- 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5 (address) — Principal executive office
- 001-39032 (other) — Commission File Number
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report a press release dated September 4, 2024, which is attached as Exhibit 99.1.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is September 4, 2024.
What is the principal executive office address for Profound Medical Corp.?
The principal executive office address for Profound Medical Corp. is 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.
What is the Commission File Number for Profound Medical Corp.?
The Commission File Number for Profound Medical Corp. is 001-39032.
Which exhibit is incorporated by reference in this filing?
Exhibit 99.1, a Press Release dated September 4, 2024, is incorporated by reference in this filing.
Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-09-04 17:02:36
Filing Documents
- f6k_090424.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 4KB
- 0001171843-24-005063.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: September 4, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer